Sputnik V Vaccine For India: 10 Things You Need To Know About The Vaccine

post image
Sputnik V vaccine against COVID-19 developed by Russia has now been approved and cleared for emergency use in India by the Drugs Controller General of India (DCGI). The vaccine was approved by the DCGI on April 11 and India is the 60th country to approve Sputnik V.

“India, the world’s 2nd most populous nation, became the 60th country to register #SputnikV after positive results of local Phase 3 clinical study. Sputnik V is now authorized in 60 countries with population of over 3 bln people,” tweeted Sputnik V official account on Twitter. Sputnik V is the third vaccine to be approved for emergency use after the Covishield vaccine and the Covaxin vaccine in India.

Here are 10 things you need to know about the Sputnik V Vaccine

  • Sputnik V vaccine is developed by Gamaleys National Research Institute of Epidemiology and Microbiology in Moscow. The vaccine was launched in Russia last August by the Russian president Vladimir Putin.
  • Sputnik V was highly criticised and faced many comments from the scientific community over the haste and lack of transparency from the developers while making the vaccine. But further trials and results proved it to be effective.
  • Sputnik V is the third vaccine that India approved for emergency use. Covishield which is developed by the Serum Institute of India and Covaxin developed by Bharat Biotech have been previously approved by the country.
  • Sputnik V vaccine will be manufactured by Dr Reddy’s Laboratories which is a Hyderabad-based pharma laboratory in India in partnership with the Russian Direct Investment Fund (RDIF).
  • The vaccine is currently in the third phase trial in the laboratories in India. Over 1500 people from a wide age group ranging from 18 to 99 are part of the clinical trials.
  • The protection that the Sputnik V vaccine can give applies to all age groups. This also includes people who are older than 60 years of age.
  • According to the trial reports from The Lancet, Sputnik V is counted among vaccines against COVID-19 with the highest efficacy at a high rate of 91.6 per cent.
  • The two shots required for the course of vaccination are given 21 days apart.
  • In studies conducted for the tests of the vaccine, no strong allergies caused by the Sputnik V vaccine were found or shown.
  • According to the Russian Direct Investment Fund (RDIF), Sputnik V uses a different vector for each of the two shots to be taken in a course of vaccination. This different vector provides immunity with a longer duration than other vaccines that use the same delivery mechanism for both shots.